CompletedPhase 4NCT01524939

Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Green Cross Corporation
Principal Investigator
June Huh, MD,Ph.D
Samsung Medical Center
Intervention
immunoglobulin G(drug)
Enrollment
45 enrolled
Eligibility
5 years · All sexes
Timeline
20122012

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01524939 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease

← Back to all trials